| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/15/2003 | US6548071 Lyophilizate of lipid complex of water insoluble camptothecins |
| 04/15/2003 | US6548062 Preferred for the treatment of prostate or pancreatic cancer. |
| 04/15/2003 | US6548054 Biocidal polystyrene hydantoin particles |
| 04/15/2003 | US6548053 Administering enzyme inhibitor |
| 04/15/2003 | US6548049 Medicinal aerosol formulation |
| 04/15/2003 | US6548041 Diagnosis, therapy of central nervous system disorders |
| 04/15/2003 | US6547769 Catheter apparatus with weeping tip and method of use |
| 04/15/2003 | US6546929 Dry powder dispersing apparatus and methods for their use |
| 04/15/2003 | US6546928 Metered dose inhaler for fluticasone propionate |
| 04/15/2003 | CA2426096A1 Sterilizing disinfectant, antimicrobial agent and antimicrobial material |
| 04/15/2003 | CA2381329C Medicaments |
| 04/15/2003 | CA2278988C An efficient synthesis of furan sulfonamide compounds useful in the synthesis of new il-1 inhibitors |
| 04/15/2003 | CA2274338C Ziprasidone formulations |
| 04/15/2003 | CA2261099C Antithrombotic and antiatherogenic pharmaceutical composition including a thienopyridine derivative and an hmg-coa-reductase inhibitor |
| 04/15/2003 | CA2259698C Trovafloxacin mesylate tablet |
| 04/15/2003 | CA2172854C Antimicrobial indole derivatives |
| 04/15/2003 | CA2169737C Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
| 04/15/2003 | CA2130516C New 11-benzaldoxime-estradiene derivatives, processes for their production and pharmaceuticals containing these substances |
| 04/15/2003 | CA2120599C Transdermal therapeutic systems containing crystallization inhibitors |
| 04/15/2003 | CA2112487C Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| 04/15/2003 | CA2099588C Prevention of synovial adhesions |
| 04/15/2003 | CA2097715C Indan derivatives |
| 04/15/2003 | CA2084775C Method of treating human prostatic adenocarcinoma |
| 04/15/2003 | CA2078466C Novel 3-cycloalkyl-propen-2-amide derivatives, tautomers and salts thereof, process for preparing the same and their use as drugs, compositions containing them |
| 04/15/2003 | CA2070573C Derivatives of amide analogs of certain methano bridged quinolizines |
| 04/15/2003 | CA2053208C Hydroxyalkylquinoline ether acids as leukotriene antagonists |
| 04/15/2003 | CA2052433C Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments |
| 04/15/2003 | CA2051504C 1-phenyl-3-aryl-2-propyne-1-ones as calcium uptake inhibitors |
| 04/15/2003 | CA2048242C 4-amino-4-steroids and their use as 5.alpha.-reductase inhibitors |
| 04/15/2003 | CA2047375C Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis |
| 04/15/2003 | CA2037975C 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors |
| 04/15/2003 | CA2036337C Derivatives of 20,21-dinoreburnamenin, their preparation process and the new intermediates thus obtained, their application as drugs and the compositions containing such |
| 04/15/2003 | CA2024124C Heterogeneous synthesis of azepinones from esters |
| 04/12/2003 | CA2407214A1 Method of monitoring neuroprotective treatment |
| 04/11/2003 | WO2004096982A2 Antibacterial agents |
| 04/11/2003 | WO2002032899A1 Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 04/11/2003 | WO2002032898A2 Novel anticholinergics, method for the production thereof and use thereof as medicaments |
| 04/11/2003 | WO2002030934A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines |
| 04/11/2003 | WO2002030928A1 Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
| 04/11/2003 | CA2506646A1 Serotonin transport inhibitors |
| 04/11/2003 | CA2425685A1 Substituted 3.4-dihydro-pyrimido[1,2-a]pyrimidines and 3.4-dihydropyrazino[1,2-a]pyrimidines |
| 04/10/2003 | WO2003029825A2 Method for predicting the sensitivity to chemotherapy |
| 04/10/2003 | WO2003029495A2 Coniosulphides and their derivatives, method for their production and use as medicaments |
| 04/10/2003 | WO2003029467A1 Candidate protein for novel cell polarization factor and polynucleotide encoding the protein |
| 04/10/2003 | WO2003029465A1 HepNaDC GENE |
| 04/10/2003 | WO2003029433A2 Chimeric viral vectors for gene therapy |
| 04/10/2003 | WO2003029428A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/10/2003 | WO2003029417A2 Nutrient medium for maintaining neural cells in injured nervous system |
| 04/10/2003 | WO2003029413A2 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | WO2003029289A2 Fragements of heat shock proteins and their use |
| 04/10/2003 | WO2003029272A2 A method of treating schizophrenia and bipolar disorders |
| 04/10/2003 | WO2003029268A1 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 04/10/2003 | WO2003029265A1 Inosinie/l-arginine salt and use thereof |
| 04/10/2003 | WO2003029264A2 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof |
| 04/10/2003 | WO2003029254A1 Process for preparation of tricyclic compounds |
| 04/10/2003 | WO2003029253A1 4-oxoquinolizine antimicrobials having 2-pyridone skeleton as partial structure |
| 04/10/2003 | WO2003029252A1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 04/10/2003 | WO2003029250A1 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system |
| 04/10/2003 | WO2003029248A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
| 04/10/2003 | WO2003029247A1 N-heterocyclyl hydrazides as neurotrophic agents |
| 04/10/2003 | WO2003029245A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | WO2003029244A1 Process for preparing pyridyl-alkylsulfonyl pyrazole derivatives |
| 04/10/2003 | WO2003029242A1 NF-λB INHIBITORS |
| 04/10/2003 | WO2003029241A1 Chk1 kinase inhibitors |
| 04/10/2003 | WO2003029238A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | WO2003029236A1 Process for the preparation of citalopram |
| 04/10/2003 | WO2003029233A1 New sulfonamide derivatives as d3-receptor agonists |
| 04/10/2003 | WO2003029232A1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/10/2003 | WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029221A1 Tetrahydroisochinolines, their production and the use thereof as analgesics |
| 04/10/2003 | WO2003029220A2 Preparation of an anhydrous quinoline-based cetp inhibitor by crystallization |
| 04/10/2003 | WO2003029217A2 Pyridinic sulfonamide derivatives, method of production and use thereof |
| 04/10/2003 | WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029215A1 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/10/2003 | WO2003029214A1 Pseudopolymorphic forms of carvedilol |
| 04/10/2003 | WO2003029213A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 04/10/2003 | WO2003029212A1 Indole derivatives as cox ii inhibitors |
| 04/10/2003 | WO2003029210A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 04/10/2003 | WO2003029209A2 Chemical compounds |
| 04/10/2003 | WO2003029206A1 Preparation of hiv protease inhibitors |
| 04/10/2003 | WO2003029205A1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 04/10/2003 | WO2003029201A1 Methods and compositions for treating or preventing bacterial infection |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2003029198A1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 04/10/2003 | WO2003029187A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003029185A1 Novel compounds |
| 04/10/2003 | WO2003029176A1 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents |
| 04/10/2003 | WO2003028990A1 Systems, methods and apparatuses for manufacturing dosage forms |
| 04/10/2003 | WO2003028989A1 Systems, methods and apparatuses for manufacturing dosage forms |
| 04/10/2003 | WO2003028781A1 Glycosaminoglycan-polycation complex crosslinked by polyfunctional crosslinking agent and process for producing the same |
| 04/10/2003 | WO2003028777A1 Inhibition of exoproteins using isoprenoids |
| 04/10/2003 | WO2003028767A2 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions and methods |
| 04/10/2003 | WO2003028763A1 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 04/10/2003 | WO2003028759A1 Rsv gene expression vaccine |
| 04/10/2003 | WO2003028755A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 04/10/2003 | WO2003028754A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 04/10/2003 | WO2003028747A1 Ingestible nerve and circulatory nutritional formulation |
| 04/10/2003 | WO2003028744A1 Process for producing collagen production enhancers and use thereof |